6-K ·Filed Jun 1, 2026
Notable filing: 6-K
Actionable Insight • Neutral
Monitor the webcast replay for any unannounced clinical or strategic updates, but this filing alone does not warrant a trading action.
Final — all horizons settled through T+60d
HELP ▲ +199.56% at T+60d
NEUTRAL call +199.56% · α vs SPY +198.44% · entry $4.55 → $13.63
T+1d
-5.49%
call -5.49% · α -4.77%
$4.30
settled 5mo ago
T+5d
-13.85%
call -13.85% · α -10.88%
$3.92
settled 5mo ago
T+20d
+38.02%
call +38.02% · α +39.59%
$6.28
settled 4mo ago
T+60d
+199.56%
call +199.56% · α +198.44%
$13.63
settled 2mo ago
Price Chart
Loading chart...
Executive Summary
Helus Pharma (Cybin Inc.) announced its interim CEO will participate in a fireside chat at the Jefferies Global Healthcare Conference on June 4, 2026. This is a routine investor relations event with no material financial or clinical data disclosed.
Key Facts
- Interim CEO Eric So will participate in a fireside chat at the Jefferies Global Healthcare Conference on June 4, 2026 at 2:35 p.m. EDT.
- The conference takes place June 2-4, 2026 in New York.
- No clinical data, financial results, or material business developments were announced.
Financial Impact
No financial figures disclosed; routine conference participation with no material impact.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
88% bullish (8 analysts)
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001833141-26-000036 |
| Document: cybininc-form6xk06x01x2026.htm | 0001833141-26-000036 |
| Document: 0001833141-26-000036-index-headers.html | 0001833141-26-000036 |
| Document: 0001833141-26-000036-index.html | 0001833141-26-000036 |
| Document: 0001833141-26-000036.txt | 0001833141-26-000036 |
37 reports for HELP
50% Hit rate @ T+20 Went positive at some point 2 of 4 best @ T+20▲ +45.91%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | 6-K | $10.66 | awaiting T+20 | — | $10.43 (−2.11%) |
Oct 26, 2026 1d ago | 3 | $10.11 | awaiting T+20 | — | $10.43 (+3.17%) |
Oct 26, 2026 1d ago | 3 | $10.86 | awaiting T+20 | — | $10.43 (−3.92%) |
Oct 23, 2026 3d ago | 3 | $10.50 | awaiting T+20 | — | $10.43 (−0.67%) |
Oct 23, 2026 3d ago | 3 | $10.50 | awaiting T+20 | — | $10.43 (−0.67%) |
Oct 23, 2026 3d ago | 3 | $10.50 | awaiting T+20 | — | $10.43 (−0.67%) |
Oct 23, 2026 3d ago | 3 | $10.50 | awaiting T+20 | — | $10.43 (−0.67%) |
Oct 21, 2026 5d ago | 6-K | $10.50 | awaiting T+20 | — | $10.43 (−0.67%) |
Oct 15, 2026 12d ago | 6-K | $11.05 | awaiting T+20 | — | $10.43 (−5.61%) |
Oct 15, 2026 12d ago | Press Release | $11.05 | awaiting T+20 | — | $10.43 (−5.61%) |
Showing 10 of 37
US Market Status
Market Open — Closes in 1h 52m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers